Provides service to scientific community working in field of drug design against drug resistant Mycobacterium tuberculosis, a causative agent of tuberculosis. MDRIpred allows uses to predict inhibitors against drug-tolerant M.tb H37Rv in different phase like replicate, non-replicative phase.It permits to submit molecule with three options: 1) by drawing structure using JME editor, 2) by pasting molecule in mol/mol2 file format, 3) By file upload.
Bioinformatics Centre, CSIR-Institute of Microbial Technology, Chandigarh, India; Infectious Diseases and Immunology, CSIR-Institute of Microbial Technology, Chandigarh, India; Centre For Microbial Biotechnology, Panjab University, Chandigarh, India; CSIR Open Source Drug Discovery Unit, Anusandhan Bhavan, Delhi, India
MDRIpred funding source(s)
Supported by Council of Scientific and Industrial Research (CSIR) (project OSDD and GENESIS BSC0121), and Department of Biotechnology (DBT) (project BTISNET).